Jeffrey Meyer

Research output

Research output per year 1999 2008 2011 2013 2015 2017 2018 2019 2021 2022 2024

• 78 Article
• 15 Review article
• 11 Comment/debate
• 4 Letter
• 8 More
  • 3 Chapter
  • 3 Editorial
  • 1 Book
  • 1 Foreword/postscript

Research output per year

Research output per year

Search results

• 2024

  Circulating Tumor DNA to Predict Radiographic and Pathologic Response to Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer

  Alden, S. L., Lee, V., Narang, A. K., Meyer, J., Gearhart, S. L. & Christenson, E. S., Mar 2024, In: Oncologist. 29, 3, p. E414-E418

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Circulating Tumor DNA 100%
  • Neoadjuvant Therapy 80%
  • Rectal Neoplasms 71%
  • Sensitivity and Specificity 25%
  • Retrospective Studies 11%

• Surgical and local control outcomes after sequential short-course radiation therapy and chemotherapy for rectal cancer

  Liu, I. C., Gearhart, S., Ke, S., Hu, C., Chung, H., Efron, J., Gabre-Kidan, A., Najjar, P., Atallah, C., Safar, B., Christenson, E. S., Azad, N. S., Lee, V., Zaheer, A., Birkness-Gartman, J. E., Reddy, A. V., Narang, A. K. & Meyer, J., Mar 2024, In: Surgery Open Science. 18, p. 42-49 8 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Rectal Neoplasms 100%
  • Consolidation Chemotherapy 72%
  • Radiotherapy 67%
  • Drug Therapy 57%
  • Neoadjuvant Therapy 56%
• 2023

  Relationship of Hepatocellular Carcinoma Stage and Hepatic Function to Health-Related Quality of Life: A Single Center Analysis

  Gupta, A., Zorzi, J., Ho, W. J., Baretti, M., Azad, N. S., Griffith, P., Dao, D., Kim, A., Philosophe, B., Georgiades, C., Kamel, I., Burkhart, R., Liddell, R., Hong, K., Shubert, C., Lafaro, K., Meyer, J., Anders, R., Burns, W. & Yarchoan, M., Sep 2023, In: Healthcare (Switzerland). 11, 18, 2571.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • cancer 100%
  • Hepatocellular Carcinoma 88%
  • quality of life 87%
  • Quality of Life 70%
  • Liver Neoplasms 68%

• Selective de-implementation of routine in vivo dosimetry

  Mao, S. P. H., Han-Oh, S., Moore, J., Huang, E., McNutt, T. R., Souranis, A. N., Briner, V., Halthore, A., Alcorn, S., Meyer, J. J., Viswanathan, A. N. & Wright, J. L., Jul 2023, In: Journal of applied clinical medical physics. 24, 7, e13953.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • In Vivo Dosimetry 100%
  • Dosimetry 74%
  • Cone-Beam Computed Tomography 67%
  • dosimeters 55%
  • Diodes 55%

• The Timing of Surgery Following Stereotactic Body Radiation Therapy Impacts Local Control for Borderline Resectable or Locally Advanced Pancreatic Cancer

  Lin, T., Reddy, A., Hill, C., Sehgal, S., He, J., Zheng, L., Herman, J., Meyer, J. & Narang, A., Feb 2023, In: Cancers. 15, 4, 1252.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Radiosurgery 100%
  • Pancreatic Neoplasms 85%
  • Proportional Hazards Models 10%
  • Radiotherapy 7%
  • Drug Therapy 6%

• Treatment Planning of Bulky Tumors Using Pencil Beam Scanning Proton GRID Therapy

  Halthore, A., Fellows, Z., Tran, A., Deville, C., Wright, J. L., Meyer, J., Li, H. & Sheikh, K., 2023, In: International Journal of Particle Therapy. 9, 3, p. 40-49 10 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Proton Therapy 100%
  • pencil beams 94%
  • Intensity-Modulated Radiotherapy 89%
  • planning 72%
  • tumors 70%
• 2022

  Chemoradiation-induced alteration of programmed death-ligand 1, CD8+ tumor-infiltrating lymphocytes and mucin expression in rectal cancer

  Baretti, M., Zhu, Q., Fu, W., Meyer, J., Wang, H., Anders, R. A. & Azad, N. S., 2022, In: Oncotarget. 13, 1, p. 907-917 11 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Tumor-Infiltrating Lymphocytes 100%
  • Mucins 84%
  • Chemoradiotherapy 84%
  • Rectal Neoplasms 80%
  • Ligands 55%

• Efficacy and Safety of Reirradiation with Stereotactic Body Radiation Therapy for Locally Recurrent Pancreatic Adenocarcinoma

  Reddy, A. V., Hill, C. S., Sehgal, S., He, J., Zheng, L., Herman, J. M., Meyer, J. & Narang, A. K., Jun 2022, In: Clinical Oncology. 34, 6, p. 386-394 9 p.

  Research output: Contribution to journal › Article › peer-review

  • Re-Irradiation 100%
  • Radiosurgery 75%
  • Adenocarcinoma 53%
  • Progression-Free Survival 53%
  • Safety 40%

• External Beam Radiation Therapy for Primary Liver Cancers: An ASTRO Clinical Practice Guideline

  Apisarnthanarax, S., Barry, A., Cao, M., Czito, B., DeMatteo, R., Drinane, M., Hallemeier, C. L., Koay, E. J., Lasley, F., Meyer, J., Owen, D., Pursley, J., Schaub, S. K., Smith, G., Venepalli, N. K., Zibari, G. & Cardenes, H., Jan 1 2022, In: Practical Radiation Oncology. 12, 1, p. 28-51 24 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Liver Neoplasms 100%
  • Practice Guidelines 94%
  • Radiotherapy 69%
  • Cholangiocarcinoma 52%
  • Hepatocellular Carcinoma 44%

• High local failure rates despite high margin-negative resection rates in a cohort of borderline resectable and locally advanced pancreatic cancer patients treated with stereotactic body radiation therapy following multi-agent chemotherapy

  Hill, C., Sehgal, S., Fu, W., Hu, C., Reddy, A., Thompson, E., Hacker-Prietz, A., Le, D., De Jesus-Acosta, A., Lee, V., Zheng, L., Laheru, D. A., Burns, W., Weiss, M., Wolfgang, C., He, J., Herman, J. M., Meyer, J. & Narang, A., Apr 2022, In: Cancer medicine. 11, 7, p. 1659-1668 10 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Radiosurgery 100%
  • Margins of Excision 95%
  • Pancreatic Neoplasms 85%
  • Drug Therapy 53%
  • Survival 25%

• High neutrophil-to-lymphocyte ratio following stereotactic body radiation therapy is associated with poor clinical outcomes in patients with borderline resectable and locally advanced pancreatic cancer

  Reddy, A. V., Hill, C. S., Sehgal, S., He, J., Zheng, L., Herman, J. M., Meyer, J. & Narang, A. K., Feb 2022, In: Journal of Gastrointestinal Oncology. 13, 1, p. 368-379 12 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Radiosurgery 100%
  • Pancreatic Neoplasms 85%
  • Neutrophils 71%
  • Lymphocytes 62%
  • Progression-Free Survival 33%

• Is PD-1 Inhibitor Monotherapy a New Standard Treatment for MMR-Deficient Locally Advanced Rectal Cancer?

  Christenson, E. S. & Meyer, J., Nov 2022, In: Current oncology reports. 24, 11, p. 1373-1375 3 p.

  Research output: Contribution to journal › Article › peer-review

  • Rectal Neoplasms 100%
  • Combined Modality Therapy 60%
  • DNA Mismatch Repair 58%
  • Neoadjuvant Therapy 56%
  • Colonic Neoplasms 44%

• Location, Location, Location: What Should be Targeted Beyond Gross Disease for Localized Pancreatic Ductal Adenocarcinoma? Proposal of a Standardized Clinical Tumor Volume for Pancreatic Ductal Adenocarcinoma of the Head: The “Triangle Volume”

  Hill, C. S., Fu, W., Hu, C., Sehgal, S., Reddy, A. V., He, J., Herman, J. M., Meyer, J. J., Zaheer, A. & Narang, A. K., May 1 2022, In: Practical Radiation Oncology. 12, 3, p. 215-225 11 p.

  Research output: Contribution to journal › Article › peer-review

  • Pancreatic Diseases 100%
  • Tumor Burden 73%
  • Adenocarcinoma 60%
  • Radiation 58%
  • Head 56%

• Nonoperative Management Following Complete Response in Rectal Cancer after Short-course Radiation Therapy and Consolidation Chemotherapy: Clinical Outcomes and Quality of Life Measures

  Reddy, A. V., Safar, B., Jia, A. Y., Azad, N. S., Christenson, E. S., Atallah, C., Efron, J. E., Gearhart, S. L., Zaheer, A., Narang, A. K. & Meyer, J., Jul 1 2022, In: American Journal of Clinical Oncology: Cancer Clinical Trials. 45, 7, p. 298-305 8 p.

  Research output: Contribution to journal › Article › peer-review

  • Consolidation Chemotherapy 100%
  • Rectal Neoplasms 68%
  • Radiotherapy 46%
  • Quality of Life 43%
  • Disease-Free Survival 27%

• Post-radiation neutrophil-to-lymphocyte ratio is a prognostic marker in patients with localized pancreatic adenocarcinoma treated with anti-PD-1 antibody and stereotactic body radiation therapy

  Reddy, A. V., Hill, C. S., Sehgal, S., Zheng, L., He, J., Laheru, D. A., De Jesus-Acosta, A., Herman, J. M., Meyer, J. & Narang, A. K., Jun 2022, In: Radiation Oncology Journal. 40, 2, p. 111-119 9 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Radiosurgery 100%
  • Adenocarcinoma 71%
  • Neutrophils 71%
  • Radiation 68%
  • Lymphocytes 62%

• Stereotactic body radiation therapy for the treatment of locally recurrent pancreatic cancer after surgical resection

  Reddy, A. V., Hill, C. S., Sehgal, S., He, J., Zheng, L., Herman, J. M., Meyer, J. & Narang, A. K., Jun 2022, In: Journal of Gastrointestinal Oncology. 13, 3, p. 1402-1412 11 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Radiosurgery 100%
  • Pancreatic Neoplasms 85%
  • Radiotherapy 62%
  • Progression-Free Survival 54%
  • Recurrence 17%

• Upfront Chemotherapy Followed by Stereotactic Body Radiation Therapy with or without Surgery in Older Patients with Localized Pancreatic Cancer: A Single Institution Experience and Review of the Literature

  Reddy, A. V., Sehgal, S., Hill, C. S., Zheng, L., He, J., Herman, J. M., Meyer, J. & Narang, A. K., Jan 2022, In: Current Oncology. 29, 1, p. 308-320 13 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Radiosurgery 100%
  • Pancreatic Neoplasms 85%
  • Progression-Free Survival 54%
  • Drug Therapy 53%
  • Survival 33%
• 2021

  Bone density and fracture risk following SBRT for non-spine bone metastases

  Cao, Y., Stachelek, G. C., Fu, W., Song, D., Hales, R. K., Voong, K. R., Meyer, J. J., Quon, H., Hu, C. & Redmond, K. J., 2021, In: Journal of Radiosurgery and SBRT. 7, 3, p. 199-206 8 p.

  Research output: Contribution to journal › Article › peer-review

  • Bone Fractures 100%
  • Bone Density 83%
  • Neoplasm Metastasis 56%
  • Bone and Bones 54%
  • Recurrence 52%

• Development, Practice Patterns, and Early Clinical Outcomes of a Multidisciplinary Liver Cancer Clinic

  Jia, A. Y., Popovic, A., Mohan, A. A., Zorzi, J., Griffith, P., Kim, A. K., Anders, R. A., Burkhart, R. A., Lafaro, K., Georgiades, C., Azad, N. S., Liddell, R. P., Baretti, M., Kamel, I. R., Narang, A., Yarchoan, M. & Meyer, J., 2021, In: Cancer Control. 28

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Physicians' Practice Patterns 100%
  • Liver Neoplasms 66%
  • Liver 10%
  • Biliary Tract Neoplasms 7%
  • Cholangiocarcinoma 5%

• Fiducial-based image-guided SBRT for pancreatic adenocarcinoma: Does inter-and intra-fraction treatment variation warrant adaptive therapy?

  Hill, C. S., Han-Oh, S., Cheng, Z., Wang, K-H., Meyer, J. J., Herman, J. & Narang, A. K., Dec 2021, In: Radiation Oncology. 16, 1, 53.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Image-Guided Radiotherapy 100%
  • Radiosurgery 78%
  • Adenocarcinoma 56%
  • Linear Models 55%
  • Respiration 29%

• Geometric Reproducibility of Fiducial Markers and Efficacy of a Patient-Specific Margin Design Using Deep Inspiration Breath Hold for Stereotactic Body Radiation Therapy for Pancreatic Cancer

  Han-Oh, S., Hill, C., Kang-Hsin Wang, K., Ding, K., Wright, J. L., Alcorn, S., Meyer, J., Herman, J. & Narang, A., Mar 1 2021, In: Advances in Radiation Oncology. 6, 2, 100655.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Fiducial Markers 100%
  • Radiosurgery 76%
  • Pancreatic Neoplasms 65%
  • Direction compound 50%
  • Tumor Burden 28%
  1 Scopus citations

• Impact of somatic mutations on clinical and pathologic outcomes in borderline resectable and locally advanced pancreatic cancer treated with neoadjuvant chemotherapy and stereotactic body radiotherapy followed by surgical resection

  Reddy, A. V., Hill, C. S., Sehgal, S., Ding, D., Hacker-Prietz, A., He, J., Zheng, L., Herman, J. M., Meyer, J. & Narang, A. K., Dec 2021, In: Radiation Oncology Journal. 39, 4, p. 304-314 11 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Radiosurgery 100%
  • Pancreatic Neoplasms 85%
  • Drug Therapy 53%
  • Mutation 50%
  • Confidence Intervals 27%

• Long-Term Results of a Phase 1 Dose-Escalation Trial and Subsequent Institutional Experience of Single-Fraction Stereotactic Ablative Radiation Therapy for Liver Metastases

  Folkert, M. R., Meyer, J. J., Aguilera, T. A., Yokoo, T., Sanford, N. N., Rule, W. G., Mansour, J., Yopp, A., Polanco, P., Hannan, R., Nedzi, L. A. & Timmerman, R. D., Apr 1 2021, In: International Journal of Radiation Oncology Biology Physics. 109, 5, p. 1387-1395 9 p.

  Research output: Contribution to journal › Article › peer-review

  • metastasis 100%
  • Radiosurgery 75%
  • liver 75%
  • radiation therapy 69%
  • dosage 45%

• Vertebral body and splenic irradiation are associated with lymphopenia in localized pancreatic cancer treated with stereotactic body radiation therapy

  Reddy, A. V., Deek, M. P., Jackson, J. F., Hill, C. S., Sehgal, S., He, J., Zheng, L., Herman, J. M., Meyer, J. & Narang, A. K., Dec 2021, In: Radiation Oncology. 16, 1, 242.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Lymphopenia 100%
  • Radiosurgery 90%
  • Pancreatic Neoplasms 77%
  • Lymphocyte Count 38%
  • Spleen 36%
• 2020

  An Integrated Program in a Pandemic: Johns Hopkins Radiation Oncology Department

  Wright, J. L., Alcorn, S., McNutt, T., Han-Oh, S., Gonzalez, R., Lin, L., Anderson, R., Wieworka, J., Deville, C., Ladra, M., Meyer, J., Hales, R., Voong, R., Narang, A., Vogel, J., Asrari, F., Kiess, A., Song, D., Tran, P. T., Kleinberg, L., & 9 othersRedmond, K., Tsien, C., Quon, H., Page, B., Croog, V., Walker, A., Greco, S., Laiho, M. & Viswanathan, A., Jul 1 2020, In: Advances in Radiation Oncology. 5, 4, p. 666-672 7 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  8 Scopus citations

• Evaluation of a Novel Absorbable Radiopaque Hydrogel in Patients Undergoing Image Guided Radiation Therapy for Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma

  Rao, A. D., Shin, E. J., Meyer, J., Thompson, E. L., Fu, W., Hu, C., Fishman, E. K., Weiss, M., Wolfgang, C., Burkhart, R., He, J., Kerdsirichairat, T., Herman, J. M., Ding, K. & Narang, A., Nov 1 2020, In: Practical Radiation Oncology. 10, 6, p. e508-e513

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Image-Guided Radiotherapy 100%
  • Hydrogels 76%
  • Adenocarcinoma 56%
  • Pancreatic Neoplasms 15%
  • Tomography 10%
  1 Scopus citations

• Feasibility and Outcome of Routine Use of Concurrent Chemoradiation in HIV-positive Patients with Squamous Cell Anal Cancer

  Leiker, A. J., Wang, C. J., Sanford, N. N., Aguilera, T. A., Karri, S., Beg, M. S., Kazmi, S. A., Olson, C., Matthews, J. A., Abdelnaby, A., Meyer, J. J. & Folkert, M. R., Oct 1 2020, In: American Journal of Clinical Oncology: Cancer Clinical Trials. 43, 10, p. 701-708 8 p.

  Research output: Contribution to journal › Article › peer-review

  • Anus Neoplasms 100%
  • Squamous Cell Neoplasms 90%
  • HIV 50%
  • Survival 36%
  • Colostomy 35%
• 2019

  4D liver tumor localization using cone-beam projections and a biomechanical model

  Zhang, Y., Folkert, M. R., Li, B., Huang, X., Meyer, J. J., Chiu, T., Lee, P., Tehrani, J. N., Cai, J., Parsons, D., Jia, X. & Wang, J., Apr 2019, In: Radiotherapy and Oncology. 133, p. 183-192 10 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Cone-Beam Computed Tomography 100%
  • Liver 46%
  • Neoplasms 29%
  • Cysts 15%
  • Finite Element Analysis 11%
  5 Scopus citations

• Comparison of treatment planning approaches for spatially fractionated irradiation of deep tumors

  Sheikh, K., Hrinivich, W. T., Bell, L. A., Moore, J. A., Laub, W., Viswanathan, A. N., Yan, Y., McNutt, T. R. & Meyer, J., Jun 2019, In: Journal of applied clinical medical physics. 20, 6, p. 125-133 9 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Intensity-Modulated Radiotherapy 100%
  • Tumors 83%
  • Irradiation 83%
  • planning 81%
  • tumors 78%
  2 Scopus citations

• Considerations of target surface area and the risk of radiosurgical toxicity

  Stojadinovic, S., Yan, Y., Leiker, A., Ahn, C., Wardak, Z., Dan, T., Nedzi, L., Timmerman, R., Patel, T., Barnett, S., Mickey, B. & Meyer, J., Oct 1 2019, In: PloS one. 14, 10, e0224047.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Radiosurgery 100%
  • Meningioma 65%
  • Linear Models 47%
  • Software 22%
  • Regression Analysis 19%

• Enhancing liver tumor localization accuracy by prior-knowledge-guided motion modeling and a biomechanical model

  Zhang, Y., Folkert, M. R., Huang, X., Ren, L., Meyer, J., Tehrani, J. N., Reynolds, R. & Wang, J., 2019, In: Quantitative Imaging in Medicine and Surgery. 9, 7, p. 1337-1349 13 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Liver 100%
  • Statistics 86%
  • Neoplasms 62%
  • Cone-Beam Computed Tomography 56%
  • Four-Dimensional Computed Tomography 14%
  3 Scopus citations

• Fellowship Training Programs in Radiation Oncology: A Snapshot From 2005 to 2017

  Doke, K., Mohamad, O., Royce, T. J., Meyer, J. & Chen, A. M., Jul 15 2019, In: International Journal of Radiation Oncology Biology Physics. 104, 4, p. 765-772 8 p.

  Research output: Contribution to journal › Article › peer-review

  • Radiation Oncology 100%
  • physicians 84%
  • education 81%
  • Education 52%
  • radiation 45%
  7 Scopus citations

• Radiation treatment planning with embedded dose escalation

  Hrinivich, W. T., McNutt, T. R. & Meyer, J. J., Aug 14 2019, In: Radiation Oncology. 14, 1, 145.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Radiotherapy 100%
  • Neoplasms 46%
  • Intensity-Modulated Radiotherapy 29%
  • Radiosurgery 26%
  • Datasets 19%
  1 Scopus citations

• Sequential short-course radiation therapy and chemotherapy in the neoadjuvant treatment of rectal adenocarcinoma

  Jia, A. Y., Narang, A., Safar, B., Zaheer, A., Murphy, A., Azad, N. S., Gearhart, S., Fang, S., Efron, J., Warczynski, T., Hacker-Prietz, A. & Meyer, J., Aug 19 2019, In: Radiation Oncology. 14, 1, 147.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Neoadjuvant Therapy 100%
  • Adenocarcinoma 67%
  • Radiotherapy 59%
  • Drug Therapy 50%
  • Proctitis 20%
  6 Scopus citations
• 2018

  A Fellow's Fate: Employment Outcomes of Radiation Oncology Fellowship Graduates

  Mohamad, O., Doke, K., Marcrom, S., Chen, A. M., Royce, T. J. & Meyer, J. J., Sep 1 2018, In: International Journal of Radiation Oncology Biology Physics. 102, 1, p. 16-17 2 p.

  Research output: Contribution to journal › Article › peer-review
  11 Scopus citations

• A Phase i Clinical Trial of the Phosphatidylserine-targeting Antibody Bavituximab in Combination with Radiation Therapy and Capecitabine in the Preoperative Treatment of Rectal Adenocarcinoma

  Meyer, J., Arriaga, Y., Anandam, J., Karri, S., Syed, S., Verma, U., Abdelnaby, A., Raja, G., Dong, Y., Beg, M. S. & Balch, G., Oct 1 2018, In: American Journal of Clinical Oncology: Cancer Clinical Trials. 41, 10, p. 972-976 5 p.

  Research output: Contribution to journal › Article › peer-review

  • bavituximab 100%
  • Capecitabine 59%
  • Phosphatidylserines 54%
  • Adenocarcinoma 37%
  • Radiotherapy 32%
  3 Scopus citations

• Developing rational combinations of immune checkpoint inhibitors and radiation therapy for gastrointestinal cancers

  Beg, M. S. & Meyer, J., Feb 1 2018, In: Journal of Gastrointestinal Oncology. 9, 1, p. 225-230 6 p.

  Research output: Contribution to journal › Article › peer-review

  • Gastrointestinal Neoplasms 100%
  • Radiotherapy 58%
  • Standard of Care 40%
  • Research Personnel 29%
  • Safety 24%
  2 Scopus citations

• Impact of socioeconomic status on pretreatment weight loss and survival in non–small-cell lung cancer

  Lau, S. K. M., Gannavarapu, B. S., Carter, K., Gao, A., Ahn, C., Meyer, J. J., Sher, D. J., Jatoi, A., Infante, R. & Iyengar, P., Feb 2018, In: Journal of oncology practice. 14, 4, p. 237-e220

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Social Class 100%
  • cancer 95%
  • Non-Small Cell Lung Carcinoma 94%
  • Weight Loss 86%
  • social status 82%
  7 Scopus citations

• Locoregional therapies for hepatocellular carcinoma and the new LI-RADS treatment response algorithm

  Kielar, A., Fowler, K. J., Lewis, S., Yaghmai, V., Miller, F. H., Yarmohammadi, H., Kim, C., Chernyak, V., Yokoo, T., Meyer, J., Newton, I. & Do, R. K., Jan 1 2018, In: Abdominal Radiology. 43, 1, p. 218-230 13 p.

  Research output: Contribution to journal › Article › peer-review

  • Data Systems 100%
  • Hepatocellular Carcinoma 64%
  • Liver 41%
  • Response Evaluation Criteria in Solid Tumors 25%
  • Radiologists 18%
  47 Scopus citations

• Prevalence and survival impact of pretreatment cancer-associated weight loss: A tool for guiding early palliative care

  Gannavarapu, B. S., Lau, S. K. M., Carter, K., Cannon, N. A., Gao, A., Ahn, C., Meyer, J. J., Sher, D. J., Jatoi, A., Infante, R. & Iyengar, P., Feb 2018, In: Journal of oncology practice. 14, 4, p. e238-e250

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Palliative Care 100%
  • cancer 94%
  • Weight Loss 85%
  • Survival 57%
  • Neoplasms 33%
  15 Scopus citations

• Rectal cancer presenting with synchronous intraperitoneal spread of disease

  Leiker, A., Khatri, G. & Meyer, J., Apr 3 2018, In: Baylor University Medical Center Proceedings. 31, 2, p. 219-221 3 p.

  Research output: Contribution to journal › Article › peer-review

  • Rectal Neoplasms 100%
  • Rectum 48%
  • Neoplasms 31%
  • Large Intestine 29%
  • Peritoneal Cavity 27%

• Skin involvement as the presenting sign of anorectal adenocarcinoma

  Leiker, A. J., Beg, M., McIlwee, B., Law, R., Khosama, L. & Meyer, J., Oct 2 2018, In: Baylor University Medical Center Proceedings. 31, 4, p. 519-521 3 p.

  Research output: Contribution to journal › Article › peer-review

  • Adenocarcinoma 100%
  • Skin 70%
  • Carcinoma 42%
  • Neoplasms 20%
• 2017

  Race- and sex-based disparities in the therapy and outcomes of squamous cell carcinoma of the anus

  Arora, N., Gupta, A., Zhu, H., Christie, A., Meyer, J. J., Khan, S. A. & Beg, M. S., Aug 2017, In: JNCCN Journal of the National Comprehensive Cancer Network. 15, 8, p. 998-1004 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Anal Canal 100%
  • Squamous Cell Carcinoma 74%
  • Survival 49%
  • Radiotherapy 30%
  • African Continental Ancestry Group 29%
  6 Scopus citations

• Recent Trends in Radiation Oncology Fellowship Training in the United States

  Mohamad, O. & Meyer, J. J., Nov 1 2017, In: International Journal of Radiation Oncology Biology Physics. 99, 3, p. 539-540 2 p.

  Research output: Contribution to journal › Article › peer-review
  11 Scopus citations

• Safety and Efficacy of Stereotactic Ablative Radiation Therapy for Renal Cell Carcinoma Extracranial Metastases

  Wang, C. J., Christie, A., Lin, M. H., Jung, M., Weix, D., Huelsmann, L., Kuhn, K., Meyer, J., Desai, N., Kim, D. W. N., Pedrosa, I., Margulis, V., Cadeddu, J., Sagalowsky, A., Gahan, J., Laine, A., Xie, X. J., Choy, H., Brugarolas, J., Timmerman, R., & 1 othersHannan, R., May 1 2017, In: International Journal of Radiation Oncology Biology Physics. 98, 1, p. 91-100 10 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • metastasis 100%
  • Radiosurgery 75%
  • radiation therapy 69%
  • Renal Cell Carcinoma 66%
  • safety 65%
  31 Scopus citations
• 2016

  A Phase I Dose-Escalation Trial of Single-Fraction Stereotactic Radiation Therapy for Liver Metastases

  Meyer, J. J., Foster, R. D., Lev-Cohain, N., Yokoo, T., Dong, Y., Schwarz, R. E., Rule, W., Tian, J., Xie, Y., Hannan, R., Nedzi, L., Solberg, T. & Timmerman, R., Jan 1 2016, In: Annals of surgical oncology. 23, 1, p. 218-224 7 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Radiosurgery 100%
  • Neoplasm Metastasis 56%
  • Liver 46%
  • Radiotherapy 44%
  • Maximum Tolerated Dose 15%
  43 Scopus citations

• Radiation-induced liver injury mimicking metastatic disease in a patient with esophageal cancer: Correlation of positron emission tomography/computed tomography with magnetic resonance imaging and literature review

  Rabe, T. M., Yokoo, T., Meyer, J., Kernstine, K. H., Wang, D. & Khatri, G., Jul 1 2016, In: Journal of computer assisted tomography. 40, 4, p. 560-563 4 p.

  Research output: Contribution to journal › Article › peer-review

  • Positron Emission Tomography Computed Tomography 100%
  • Esophageal Neoplasms 93%
  • Radiation 68%
  • Magnetic Resonance Imaging 60%
  • Liver 47%
  5 Scopus citations
• 2015

  Adrenal insufficiency after stereotactic body radiation therapy for bilateral adrenal metastases

  Wardak, Z., Meyer, J., Ghayee, H., Wilfong, L. & Timmerman, R., May 2015, In: Practical Radiation Oncology. 5, 3, p. e177-e181

  Research output: Contribution to journal › Article › peer-review
  3 Scopus citations

• Employment after Radiation Oncology Residency: A Survey of the Class of 2014

  Bland, R. E., Hodges, J. C., Folkert, M. R., Iyengar, P. & Meyer, J. J., Aug 1 2015, In: International Journal of Radiation Oncology Biology Physics. 92, 5, p. 969-970 2 p.

  Research output: Contribution to journal › Article › peer-review
  10 Scopus citations

• Neutrophil-lymphocyte and platelet-lymphocyte ratios as prognostic factors after stereotactic radiation therapy for early-stage non-small-cell lung cancer

  Cannon, N. A., Meyer, J., Iyengar, P., Ahn, C., Westover, K. D., Choy, H. & Timmerman, R., Feb 6 2015, In: Journal of Thoracic Oncology. 10, 2, p. 280-285 6 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Radiosurgery 100%
  • Non-Small Cell Lung Carcinoma 81%
  • Neutrophils 71%
  • Blood Platelets 70%
  • Lymphocytes 62%
  113 Scopus citations